Listed on GrantGunner. Last checked 13 Nov 2026.
About this grant
AMED's initiative supports the development of treatments for intractable and rare diseases. There are frameworks for feasibility studies (up to 200 million yen) and international joint clinical trials (up to 3 billion yen, subsidy rate 1/2), targeting drug discovery, international collaborative research, and clinical trial fields.
Who can apply
Researcher affiliated with a domestic research institution. An individual engaged in the development of pharmaceuticals or regenerative medical products for intractable or rare diseases (with fewer than 50,000 patients in Japan).